Target intelligence / Profile preview

Long intergenic non-protein coding RNA 302 (LINC00302)

Target
LINC00302
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 302 (LINC00302) is a long non-coding RNA (lncRNA) classified specifically as a long intergenic non-coding RNA (lincRNA). It is encoded on human chromosome 1 (loc: 1q21.3; NCBI Gene ID 388699) and is not translated into a protein. LINC00302 has been identified as a candidate regulatory RNA in skin biology, particularly implicated in the modulation of skin barrier function and inflammatory signaling. It is associated with processes such as tissue remodeling and wound healing, with evidence that overexpression in dermal fibroblasts enhances cell viability and upregulates critical extracellular matrix components, suggesting a function in skin integrity and recovery from injury. LINC00302 has also been found differentially expressed in settings of skin inflammation (e.g., atopic dermatitis, psoriasis) and tissue repair, indicating involvement in these biological pathways. No current evidence defines it as a direct therapeutic target (i.e., not a receptor, enzyme, transporter, or transcription factor), and there are no known drugs that directly interact with it or validated mechanisms of action for pharmacological modulation of LINC00302. There are no well-documented safety concerns at this time.

Other names
XP33C1orf46NCRNA00302xp33LINC00302
02

Biological functions

Regulation of epidermal barrier functionModulation of inflammatory responsesEnhancement of cell viabilityRegulation of extracellular matrix component expression (e.g., α-SMA, Collagen I)Tissue remodeling and wound healing
03

Disease associations

Inflammatory skin disorders (including atopic dermatitis and psoriasis)Tissue repair (wound healing)
04

Biomarkers

Possible biomarker for skin integrity and wound healing, but not established or clinically validated

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 302 (LINC00302).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 302 (LINC00302).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call